Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein L (hnRNP L) is an abundant nuclear protein encoded by the HNRNPL gene that belongs to the hnRNP superfamily, which is essential in RNA metabolism[1][6][8]. hnRNP L contains four RNA recognition motif (RRM) domains that mediate specific binding to CA-repeat or CA-rich RNA sequences and is a core component of hnRNP complexes critical for the formation, packaging, processing, and function of precursor and mature mRNA[1][5]. Beyond splicing, hnRNP L regulates mRNA stabilization, IRES-mediated translation, and is implicated in DNA repair, particularly during processes such as class switch recombination in immunoglobulin genes and response to DNA damage in cancer cells[7]. It interacts with other hnRNPs and key splicing factors, and its location can shift from nucleus to cytoplasm in response to stimuli such as hypoxia[3][5]. Aberrant expression or mislocalization of hnRNP L is associated with various disease states, especially certain cancers and viral infections, and it may play a pathophysiological role in neurological disorders[6]. While not a current direct drug target, its regulatory functions in gene expression, splicing, and translation underscore its centrality to fundamental cellular processes and disease mechanisms.
Blockade of RNA-protein interactions (e.g., RNA aptamer binding to hnRNP L inhibits viral RNA translation); Modulation of pre-mRNA alternative splicing; Regulation of DNA repair processes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein L (hnRNP L).